Latest VIVUS Inc. Stories
MOUNTAIN VIEW, Calif., Sept. 20, 2012 /PRNewswire/ -- VIVUS, Inc. (Nasdaq:VVUS) today announced that multiple scientific abstracts will be presented at Obesity 2012, the 30th Annual Scientific Meeting of The Obesity Society, to be held September 20(th) to September 24(th) in San Antonio, Texas. The Obesity Society's Annual Scientific Meeting has grown to be one of the largest gatherings of obesity professionals worldwide. The posters will be displayed in Exhibit Hall C of the Henry...
MOUNTAIN VIEW, Calif., Sept. 18, 2012 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced the U.S. market availability of Qsymia(TM) (pronounced Kyoo sim ee' uh). Qsymia is FDA-approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese), or 27 or greater (overweight) in the presence of at least one weight-related comorbidity, such as...
VANCOUVER, British Columbia, Aug. 20, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Microsoft (NASDAQ:MSFT), AT&T (NYSE:T), VIVUS (NASDAQ:VVUS), Aeropostale (NYSE:ARO), Caterpillar (NYSE:CAT), and ARMOUR Residential REIT (NYSE:ARR). (Logo: http://photos.prnewswire.com/prnh/20120813/HK56225LOGO ) (Read full report by clicking the link below, you may need to copy and paste the...
VANCOUVER, British Columbia, July 24, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Bank of America (NYSE:BAC), Hewlett-Packard (NYSE:HPQ), VIVUS (NASDAQ:VVUS), Banco Bradesco SA (NYSE:BBD), EnCana (NYSE:ECA), and Suncor Energy (NYSE:SU). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your...
MOUNTAIN VIEW, Calif., July 17, 2012 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that the U.S. Food and Drug Administration (FDA) has approved Qsymia(TM) (pronounced Kyoo sim ee' uh) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese), or 27 or greater (overweight) in the presence of at least one weight-related comorbidity, such as...
VANCOUVER, British Columbia, July 17, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Bank of America (NYSE:BAC), Apple (NASDAQ:AAPL), Chesapeake Energy (NYSE:CHK), Alnylam (NASDAQ:ALNY), VIVUS (NASDAQ:VVUS), and US Airways Group (NYSE:LCC). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your...
VANCOUVER, British Columbia, June 28, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Lincare (NASDAQ:LNCR), Halliburton (NYSE:HAL), VIVUS (NASDAQ:VVUS), General Mills (NYSE:GIS), Barrick Gold (NYSE:ABX), and Deere & Company (NYSE:DE). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your...
VANCOUVER, British Columbia, May 14, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Micron (NASDAQ:MU), Sara Lee (NYSE:SLE), Nordstrom (NYSE:JWN), Best Buy (NYSE:BBY), Suncor Energy (NYSE:SU), and VIVUS (NASDAQ:VVUS). (Logo: http://photos.prnewswire.com/prnh/20120307/HK65974LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your...
The US Food and Drug Administration (FDA) voted on Friday to approve a new drug to treat erectile dysfunction (ED), various media outlets have reported. The medication, Stendra (genetic name: avanafil), is produced by California-based pharmaceutical company Vivus Inc. and is the first product from that company to receive FDA approval, according to Jennifer Corbett Dooren of the Wall Street Journal. Like Viagra, Cialis, and Levitra, Stendra is a phosphodiesterase type 5 (PDE-5) inhibitor...
MOUNTAIN VIEW, Calif., April 27, 2012 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S. "Patients and treating physicians continue to report significant dissatisfaction with current treatments of...
